Clinician holding mammogram

AI to be trialled in breast cancer screening for first time in England

Innovative artificial intelligence (AI) software is set to be used in breast cancer screening as part of a ground-breaking new trial in Yorkshire.

The Leeds Investigation of Breast-screening AI (LIBRA) study will be conducted at Leeds Teaching Hospitals NHS Trust after NHS England’s £100m AI in Health and Care Award confirmed the funding for the project.

The programme will involve the evaluation of an AI reader, which will analyse mammograms for signs of cancer. Currently, every mammogram is reviewed by two clinicians and if an agreement can’t be reached a third human reader is brought in.

During LIBRA, if the two health professionals can both agree with the AI that a mammogram is normal, the patient will get the all-clear. If an agreement can’t be reached, additional reviewers will be brought in and the usual arbitration process will proceed.

Researchers hope that, if the study shows promising results, an AI reader could replace one of the two human readers in the standard model of care, which would allow healthcare staff to spend more time with patients and increase clinical activity.

This could help the 30% shortfall in clinical radiologists which is leading to longer waiting times and worse health outcomes, according to the Royal College of Radiologists.

Consultant Breast Radiologist at the trust, and Chief Investigator for the study, Dr Nisha Sharma, said: “The LIBRA study is important because AI will help us to sustain a high quality service in the future. Breast screening isn’t perfect and it is hoped that the LIBRA study will lead to improvements in reviewing mammograms.

“Cancers that present between screening rounds are often quite aggressive and the reason these can be overlooked is because they are not clearly visible on a mammogram. AI works differently to humans and by combining human expertise with technology advances this could lead to earlier detection of cancers and impact positively on women’s lives.

“We will be the first breast screening unit in England to do a prospective study using AI. This is another exciting example of Leeds Teaching Hospitals NHS Trust leading the way in innovation.”

Earlier research that used anonymised datasets indicated the AI reader was “non-inferior” to humans and thus could help relieve workloads by “significant” amounts.

The trial is set to begin later this year as the trust sets about recruiting almost 7,000 women.

NHE March/April 2024

NHE March/April 2024

A window into the past, present and future of healthcare leadership.

- Steve Gulati, University of Birmingham 

More articles...

View all
Online Conference

Presenting

2024 Online Conferences

In partnership with our community of health sector leaders responsible for delivering the UK's health strategy across the NHS and the wider health sector, we’ve devised a collaborative calendar of conferences and events for industry leaders to listen, learn and collaborate through engaging and immersive conversation. 

All our conferences are CPD accredited, which means you can gain points to advance your career by attending our online conferences. Also, the contents are available on demand so you can re-watch at your convenience.

National Health Executive Podcast

Ep 42. Leadership in the NHS

In episode 42 of the National Health Executive podcast we were joined by Steve Gulati who is an associate professor at the University of Birmingham as well as director of healthcare leadership at the university’s Health Services Management Centre.